License an asset
Access compounds, intellectual property or applications generated through a 4Ammonium technology platform.
Partnering
From scientific potential to a transferable opportunity
We work with companies and research organisations to develop, validate and convert new therapeutic technologies into transferable assets.
Start a conversationHow we can work together
Different starting points, one defined outcome
Whether applied internally or through a partnership, 4Ammonium's technology is built to do one thing: turn a scientific hypothesis into a validated, investable asset.
Collaboration models
Built around the opportunity
We adapt the collaboration model to what each project needs: from the origin of the asset to the capabilities required and the development route ahead.
Co-develop a programme
Bring 4Ammonium's chemistry and expertise to work alongside your team.
Apply our technology
Explore whether a 4Ammonium platform can create new value for an externally supplied molecule or programme.
Establish a scientific collaboration
Generate evidence, validate a mechanism or evaluate a technology with academic, clinical or industrial groups.
Our approach
A practical route to collaboration
Responsibilities, evidence requirements and intellectual-property are carefully considered and defined around the needs of each programme.
01
Define the opportunity
Understand the molecule, therapeutic objective or technology challenge.
02
Assess platform fit
Identify where an existing technology, asset or chemistry approach can contribute.
03
Establish a route
Define validation work, responsibilities, intellectual property and the intended transfer model.
04
Generate a result
Work towards a clear outcome: data, a compound, an application, an asset or a broader programme.
Start a conversation
Tell us what you are trying to solve
If you have a molecule, delivery challenge or therapeutic hypothesis that could benefit from our technologies, we would be pleased to explore it with you.
Discuss a partnering opportunity